Positron Corporation announced the release of the PosiRx(R) 3000-Series, its latest pharmacy automation systems. The PosiRx(R) 3000-Series are the first systems to automate and encompass the complete compounding process, from generator elution to dose distribution, of multiple diagnostic SPECT agents in an environment engineered to be ISO Class 5 and USP 797 compliant. Designed for facilities dispensing as many as three hundred patient-specific doses per day, the PosiRx(R) 3000-Series will benefit providers and patients by enabling unit dose radiopharmaceuticals to be prepared more cost effectively and accurately than previously possible. The PosiRx(R) line of automation systems features DoseLink(TM), Positron's proprietary software.

Developed for precision and customer ease of use, DoseLink(TM) maximizes the functionality and efficiency of operating the PosiRx(R) system through a robust and intuitive interface that can be operated from a variety of interfaces. Whether accessed from a desktop, tablet or smartphone, DoseLink(TM) empowers the user to control drug preparation and plan daily production, as well as store and retrieve data in a secure environment. Additionally, the operator may interact with Positron support personnel for assistance with any task in real time, across any platform.